Abstract
In the United States alone, 4.8 million people suffer from congestive heart failure (CHF). Approximately 550,000 new cases of CHF are diagnosed each year (1). As the population ages, the magnitude of this problem is projected to increase (2). After diagnosis, despite improvements in medical management, 5-year mortality is 60% for men and 45% for women (1). There are 150,000 people in the end stage of this disease, and there is a 5-year mortality that approaches 100% despite the use of angiotensin II-converting enzyme inhibitors (3). Approximately half of these patients have heart failure from idiopathic, infectious, or valvular etiologies unrelated to coronary artery disease (4).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence and survival with heart failure. N Engl J Med 2002;347:1397–1402.
Loop FD. Coronary artery surgery: the end of the beginning. Eur J Cardiothorac Surg 1998;14:554–571.
Swedberg K, Kjekshus J, Snapinn S. Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I. Eur Heart J 1999;20:136–139.
McMurray JJ, Stewart S. Epidemiology, aetiology and prognosis of heart failure. Heart 2000;83:596–602.
Batista RJV, Santos JLV, Takeshita N, et al. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Card Surg 1996;11:96–97.
Beck CS. Operation for aneurysm of the heart. Ann Surg 1944; 120:34–50.
Likoff W, Bailey CP. Ventriculoplasty: excision of myocardial aneurysm. JAMA 1958;915–928.
Cooley DA, Collins HA, Morris GC, et al. Ventricular aneurysm after myocardial infarction: surgical excision with the use of cardiopulmonary bypass. JAMA 1958;167:557.
Dor V, Kreitmann P, Jourdan J, et al. Interest of physiological closure (circumferential plasty on contractile areas) of left ventricle after resection and endo-cardectomy for aneurysm of akinetic zone comparison with classical technique about a series of 209 left ventricular resections. J Cardiovasc Surg 1985;26:73.
Batista RJV, Verde J, Nery P, et al. Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg 1997;64:634–638.
McCarthy PM, Starling RC, Wong J, et al. Early results with partial left ventriculectomy. J Thorac Cardiovasc Surg 1997;114:755–765.
Moreira LF, Stolff NAG, Bocchi EA, et al. Partial left ventriculectomy with mitral valve preservation in the treatment of dilated cardiomyopathy. J Thorac Cardiovasc Surg 1998;115:800–807.
Gradinac S, Miric M, Popovic Z, et al. Partial left ventriculectomy for idiopathic dilated cardiomyopathy: early results and 6-month follow-up. Ann Thorac Surg 1998;66:1963–1968.
Franco-Cereceda A, McCarthy PM, Blackstone EH, et al. Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation? J Thorac Cardiovasc Surg 2001;121:879–893.
Dickstein ML, Spotnitz HM, Rose EA, Burkhoff D. Heart reduction surgery: an analysis of the impact on cardiac function. J Thorac Cardiovasc Surg 1997;113:1032–1040.
Gorcsan J 3rd, Feldman AM, Kormos RL, Mandarino WA, Demetris AJ, Batista RJ. Heterogeneous immediate effects of partial left ventriculectomy on cardiac performance. Circulation 1998;97:839–842.
Artrip JH, Oz MC, Burhoff D. Left ventricular volume reduction surgery for heart failure: a physiologic perspective. J Thorac Cardiovasc Surg 2001;122:775–782.
Kawaguchi AT, Suma H, Konertz W, et al. Partial left ventriculectomy: the Second International Registry Report 2000. J Card Surg 2001;16:10–23.
Bhat G, Dowling RD. Evaluation of predictors of clinical outcome after partial left ventriculectomy. Ann Thorac Surg 2001;72:91–95.
Kawaguchi AT, Bergsland J, Ishibashi-Ueda H, et al. Partial left ventriculectomy in patients with dilated failing ventricle. J Card Surg 1998;13:335–342.
Suma H, the RESTORE group. Left ventriculoplasty for nonischemic dilated cardiomyopathy. Semin Thorac Cardiovasc Surg 2001;13:514–521.
Hoercher KJ, Starling RC, McCarthy PM, Blackstone EH, Young JB. Partial left ventriculectomy: lessons learned and future implications for surgical trials. Circulation 2002;106:II–418.
Kaplon R, Lombardi P. Passive constraint and new shape-change devices for heart failure. Semin Thorac Cardiovasc Surg 2002;14:150–156.
Oz MC. Passive ventricular constraint for the treatment of congestive heart failure. Ann Thorac Surg 2001;71:S185–S187.
Saavedra FW, Tunn R, Mishima T, et al. Reverse remodeling and enhanced adrenergic reserve from a passive external ventricular support in experimental dilated heart failure. Circulation 2000;102(suppl II):II–501.
Chaudry PA, Mishima T, Sharov VG, et al. Passive epicardial containment prevents ventricular remodeling in heart failure. Ann Thorac Surg 2000;70:1275–1280.
Power J, Raman J, Byrne M. Passive ventricular constraint is a trigger for a significant degree of reverse remodeling in an experimental model of degenerative heart failure and dilated cardiomyopathy. Circulation 2000;102(suppl II):II–502.
Sabbah HN, Gupta RC, Sharov VG, et al. Prevention of progressive left ventricular dilation with the Acorn cardiac support device (CSD) down regulates stretch-mediated P21ras, attenuates myocardial hypertrophy, and improves sarcoplasmic reticulum calcium cycling in dogs with heart failure. Circulation 2000;102(suppl II):II–683.
Pilla JJ, Blom AS, Brockman DJ, et al. Ventricular constraint using the Acorn cardiac support device reduces myocardial akinetic area in an ovine model of acute infarction. Circulation 2002;106(12 suppl l):I207–I211.
Konertz WF, Shapland JE, Hotz H, et al. Passive containment and reverse remodeling by a novel textile cardiac support device. Circulation 2001;104:I-270–I-275.
Raman JS, Hata M, Storere JM, et al. The mid-term results of ventricular containment (Acorn Wrap) for end stage ischemic cardiomyopathy. Ann Thorac Cardiovasc Surg 2001;5:278–281.
McCarthy PM, Takagaki M, Ochiai Y, et al. Device-based change in left ventricular shape: a new concept for the treatment of dilated cardiomyopathy. J Thorac Cardiovasc Surg 2001;122:482–490.
Schenk S, Reichenspurner H, Boehm DH, et al. Myosplint implant and shape-change procedure: intra-and peri-operative safety and feasibility. J Heart Lung Transplant 2002;21:680–686.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Lee, R., Quader, M.A., Hoercher, K.J., McCarthy, P.M. (2005). Left Ventricular Volume Reduction Surgery for Idiopathic Dilated Cardiomyopathy. In: Fang, J.C., Couper, G.S. (eds) Surgical Management of Congestive Heart Failure. Contemporary Cardiology. Humana Press. https://doi.org/10.1385/1-59259-842-0:191
Download citation
DOI: https://doi.org/10.1385/1-59259-842-0:191
Publisher Name: Humana Press
Print ISBN: 978-1-58829-034-2
Online ISBN: 978-1-59259-842-7
eBook Packages: MedicineMedicine (R0)